Hongquan Liu named Simcere CEO
This article was originally published in Scrip
Executive Summary
Chinese pharma company Simcere Pharmaceutical has appointed Hongquan Liu CEO and executive director of the board, effective 8 October 2012. Since 2000, Mr Liu has been director and general manager of Sino-Swed Pharmaceutical Corp.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.